VentraSciencesTrending

A short synthetic tripeptide bioregulator (Ala-Glu-Asp), studied in the literature for its role in gene-expression regulation and cellular-senescence research models. For laboratory research use only.
Card fields are hosted by our payment provider, so card numbers are never received or stored by Ventra. Apple Pay, Google Pay and Link are also available at checkout.
Technical specifications
Cartalax is a synthetic tripeptide bioregulator with the Ala-Glu-Asp (AED) sequence, supplied as a lyophilized powder for in vitro laboratory research use only. It belongs to the Khavinson family of short peptide bioregulators and appears in the peer-reviewed literature in studies of gene expression, protein synthesis regulation, and cellular-aging research models in cultured fibroblasts and mesenchymal stem cells.
Research applications: Commonly used in gene-expression regulation studies, cellular-senescence research models, and short-peptide bioregulator research applications.
Peer-reviewed research
References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.
This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.
This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must comply with applicable institutional, local, and federal regulations.
By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.
Exclusive updates and restock alerts, straight to your inbox.